Wegovy® (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight; and that may help adults and children aged 12 years and older with obesity, or some adults with overweight who also have weight-related medical problems, to help them lose excess body weight and keep the weight off.
The active ingredient in Wegovy® is semaglutide, approved by the FDA for long-term weight management.
Because Wegovy® contains semaglutide, it should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines.